Amid the COVID-19 crisis, the global market for Proteomics estimated at US$18 Billion in the year 2020, is projected to reach a revised size of US$36.6 Billion by 2027, growing at a CAGR of 10.7% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 11.6% CAGR and reach US$27.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 8.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $4.9 Billion, While China is Forecast to Grow at 14.2% CAGR
The Proteomics market in the U.S. is estimated at US$4.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.9 Billion by the year 2027 trailing a CAGR of 14.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.
Services Segment to Record 7.2% CAGR
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.7 Billion in the year 2020 will reach a projected size of US$2.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.3 Billion by the year 2027, while Latin America will expand at a 8.5% CAGR through the analysis period. We bring years of research experience to this 18th edition of our report. The 312-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
- ActivX Biosciences Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Bruker Daltonics Inc.
- Caprion Biosciences Inc.
- Digilab Inc.
- GE Healthcare
- Geneva Bioinformatics S.A.
- Merck KGaA
- Millipore Sigma
- PerkinElmer Inc.
- Shimadzu Corp.
- Thermo Fischer Scientific Inc.
- Waters Corp.
- Xencor Inc.
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Proteomics - The Current Spotlight
Recent Market Activity
Proteomics Market to Grow at a Phenomenal Rate
Proteomics: A Critical Drug Discovery Tool
Research to Dominate the Market in the Immediate Future
The Stoller Biomarker Discovery Centre - Establishing the Most Comprehensive Proteomics Solutions
Proteomics Technologies: Growing in Significance
Proteomics Technological Developments and Innovations
New Technological Advancements
Innovations in Proteomics
Global Competitor Market Shares
Proteomics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ActivX Biosciences, Inc. (USA)
Agilent Technologies, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Bruker Daltonics, Inc. (USA)
Caprion Biosciences, Inc. (Canada)
Digilab, Inc. (USA)
GE Healthcare (United Kingdom)
Geneva Bioinformatics S.A. (Switzerland)
Merck KGaA (Germany)
PerkinElmer, Inc. (USA)
Shimadzu Corporation (Japan)
Millipore Sigma (USA)
Thermo Fisher Scientific, Inc. (USA)
Waters Corp. (USA)
Xencor, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Personalized Medicine Market Driven by Constraints in Traditional Treatment Approach
Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
Rising Investment in Proteomics R&D
Ballooning Global Population Offers Significant Growth Opportunities
Aging Global Population Drives Proteomics
Advancements in Proteomics Bring Biomarkers into Limelight
List of US-FDA Approved Biomarkers for Cancer
Oncology - A Key Focus Area for Proteomics
International Initiatives in the Proteomics Market
China All Set To Play a Major Role in the Proteomics Industry
Global Proteomics Sample Preparation Market - On a Growth Curve
Challenges Facing Proteomics Sample Preparation Market
Industrialization of Proteomics Research Propels Sample Preparation Technologies
Factors Limiting Market Growth
Market Restrains/Challenges
Expensive Equipment
Lack of Proficient Researchers
Protein Chemistry and its Complexities
Quantitation
Integration of Data & Equipment
Data Validation - A Burning Issue
Standardization & Consistency - A Prime Concern
Incomplete and Disorganized Data
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Proteomics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Proteomics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Proteomics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Reagents (Component) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Reagents (Component) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Reagents (Component) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Instruments (Component) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Instruments (Component) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Instruments (Component) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Services (Component) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Services (Component) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Services (Component) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Drug Discovery (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
TABLE 14: Drug Discovery (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
TABLE 15: Drug Discovery (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Disease Diagnostics (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 17: Disease Diagnostics (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
TABLE 18: Disease Diagnostics (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Other Applications (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
TABLE 20: Other Applications (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
TABLE 21: Other Applications (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Proteomics Market Share (in %) by Company: 2018 & 2025
Market Analytics
TABLE 22: United States Proteomics Market Estimates and Projections in US$ Million by Component: 2020 to 2027
TABLE 23: Proteomics Market in the United States by Component: A Historic Review in US$ Million for 2012-2019
TABLE 24: United States Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 25: United States Proteomics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
TABLE 26: Proteomics Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
TABLE 27: Proteomics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
TABLE 28: Canadian Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020 to 2027
TABLE 29: Canadian Proteomics Historic Market Review by Component in US$ Million: 2012-2019
TABLE 30: Proteomics Market in Canada: Percentage Share Breakdown of Sales by Component for 2012, 2020, and 2027
TABLE 31: Canadian Proteomics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 32: Proteomics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 33: Canadian Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
TABLE 34: Japanese Market for Proteomics: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2020-2027
TABLE 35: Proteomics Market in Japan: Historic Sales Analysis in US$ Million by Component for the Period 2012-2019
TABLE 36: Japanese Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 37: Japanese Demand Estimates and Forecasts for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 38: Japanese Proteomics Market in US$ Million by Application: 2012-2019
TABLE 39: Proteomics Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
CHINA
TABLE 40: Chinese Proteomics Market Growth Prospects in US$ Million by Component for the Period 2020-2027
TABLE 41: Proteomics Historic Market Analysis in China in US$ Million by Component: 2012-2019
TABLE 42: Chinese Proteomics Market by Component: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 43: Chinese Demand for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 44: Proteomics Market Review in China in US$ Million by Application: 2012-2019
TABLE 45: Chinese Proteomics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Proteomics Market: Competitor Market Share Scenario (in %) for 2018 & 2025
Market Analytics
TABLE 46: European Proteomics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 47: Proteomics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 48: European Proteomics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 49: European Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020-2027
TABLE 50: Proteomics Market in Europe in US$ Million by Component: A Historic Review for the Period 2012-2019
TABLE 51: European Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 52: European Proteomics Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 53: Proteomics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 54: European Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
FRANCE
TABLE 55: Proteomics Market in France by Component: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 56: French Proteomics Historic Market Scenario in US$ Million by Component: 2012-2019
TABLE 57: French Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 58: Proteomics Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
TABLE 59: French Proteomics Historic Market Review in US$ Million by Application: 2012-2019
TABLE 60: French Proteomics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
TABLE 61: Proteomics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 62: German Proteomics Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 63: German Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 64: Proteomics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
TABLE 65: German Proteomics Market in Retrospect in US$ Million by Application: 2012-2019
TABLE 66: Proteomics Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
ITALY
TABLE 67: Italian Proteomics Market Growth Prospects in US$ Million by Component for the Period 2020-2027
TABLE 68: Proteomics Historic Market Analysis in Italy in US$ Million by Component: 2012-2019
TABLE 69: Italian Proteomics Market by Component: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 70: Italian Demand for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 71: Proteomics Market Review in Italy in US$ Million by Application: 2012-2019
TABLE 72: Italian Proteomics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
TABLE 73: United Kingdom Market for Proteomics: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2020-2027
TABLE 74: Proteomics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Component for the Period 2012-2019
TABLE 75: United Kingdom Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 76: United Kingdom Demand Estimates and Forecasts for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 77: United Kingdom Proteomics Market in US$ Million by Application: 2012-2019
TABLE 78: Proteomics Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
SPAIN
TABLE 79: Spanish Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020 to 2027
TABLE 80: Spanish Proteomics Historic Market Review by Component in US$ Million: 2012-2019
TABLE 81: Proteomics Market in Spain: Percentage Share Breakdown of Sales by Component for 2012, 2020, and 2027
TABLE 82: Spanish Proteomics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 83: Proteomics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 84: Spanish Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
RUSSIA
TABLE 85: Russian Proteomics Market Estimates and Projections in US$ Million by Component: 2020 to 2027
TABLE 86: Proteomics Market in Russia by Component: A Historic Review in US$ Million for 2012-2019
TABLE 87: Russian Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 88: Russian Proteomics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
TABLE 89: Proteomics Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019
TABLE 90: Proteomics Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 91: Rest of Europe Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020-2027
TABLE 92: Proteomics Market in Rest of Europe in US$ Million by Component: A Historic Review for the Period 2012-2019
TABLE 93: Rest of Europe Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 94: Rest of Europe Proteomics Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 95: Proteomics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 96: Rest of Europe Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 97: Asia-Pacific Proteomics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 98: Proteomics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 99: Asia-Pacific Proteomics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 100: Proteomics Market in Asia-Pacific by Component: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 101: Asia-Pacific Proteomics Historic Market Scenario in US$ Million by Component: 2012-2019
TABLE 102: Asia-Pacific Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 103: Proteomics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
TABLE 104: Asia-Pacific Proteomics Historic Market Review in US$ Million by Application: 2012-2019
TABLE 105: Asia-Pacific Proteomics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
AUSTRALIA
TABLE 106: Proteomics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 107: Australian Proteomics Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 108: Australian Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 109: Proteomics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
TABLE 110: Australian Proteomics Market in Retrospect in US$ Million by Application: 2012-2019
TABLE 111: Proteomics Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
INDIA
TABLE 112: Indian Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020 to 2027
TABLE 113: Indian Proteomics Historic Market Review by Component in US$ Million: 2012-2019
TABLE 114: Proteomics Market in India: Percentage Share Breakdown of Sales by Component for 2012, 2020, and 2027
TABLE 115: Indian Proteomics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 116: Proteomics Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 117: Indian Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
SOUTH KOREA
TABLE 118: Proteomics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 119: South Korean Proteomics Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 120: Proteomics Market Share Distribution in South Korea by Component: 2012 VS 2020 VS 2027
TABLE 121: Proteomics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
TABLE 122: South Korean Proteomics Historic Market Analysis in US$ Million by Application: 2012-2019
TABLE 123: Proteomics Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
TABLE 124: Rest of Asia-Pacific Market for Proteomics: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2020-2027
TABLE 125: Proteomics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Component for the Period 2012-2019
TABLE 126: Rest of Asia-Pacific Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 127: Rest of Asia-Pacific Demand Estimates and Forecasts for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 128: Rest of Asia-Pacific Proteomics Market in US$ Million by Application: 2012-2019
TABLE 129: Proteomics Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
LATIN AMERICA
TABLE 130: Latin American Proteomics Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 131: Proteomics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 132: Latin American Proteomics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 133: Latin American Proteomics Market Growth Prospects in US$ Million by Component for the Period 2020-2027
TABLE 134: Proteomics Historic Market Analysis in Latin America in US$ Million by Component: 2012-2019
TABLE 135: Latin American Proteomics Market by Component: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 136: Latin American Demand for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 137: Proteomics Market Review in Latin America in US$ Million by Application: 2012-2019
TABLE 138: Latin American Proteomics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
ARGENTINA
TABLE 139: Argentinean Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020-2027
TABLE 140: Proteomics Market in Argentina in US$ Million by Component: A Historic Review for the Period 2012-2019
TABLE 141: Argentinean Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 142: Argentinean Proteomics Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 143: Proteomics Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 144: Argentinean Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
BRAZIL
TABLE 145: Proteomics Market in Brazil by Component: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 146: Brazilian Proteomics Historic Market Scenario in US$ Million by Component: 2012-2019
TABLE 147: Brazilian Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 148: Proteomics Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027
TABLE 149: Brazilian Proteomics Historic Market Review in US$ Million by Application: 2012-2019
TABLE 150: Brazilian Proteomics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
MEXICO
TABLE 151: Proteomics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 152: Mexican Proteomics Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 153: Mexican Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 154: Proteomics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
TABLE 155: Mexican Proteomics Market in Retrospect in US$ Million by Application: 2012-2019
TABLE 156: Proteomics Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
TABLE 157: Rest of Latin America Proteomics Market Estimates and Projections in US$ Million by Component: 2020 to 2027
TABLE 158: Proteomics Market in Rest of Latin America by Component: A Historic Review in US$ Million for 2012-2019
TABLE 159: Rest of Latin America Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 160: Rest of Latin America Proteomics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
TABLE 161: Proteomics Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019
TABLE 162: Proteomics Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
MIDDLE EAST
TABLE 163: The Middle East Proteomics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 164: Proteomics Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 165: The Middle East Proteomics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 166: The Middle East Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020 to 2027
TABLE 167: The Middle East Proteomics Historic Market by Component in US$ Million: 2012-2019
TABLE 168: Proteomics Market in the Middle East: Percentage Share Breakdown of Sales by Component for 2012,2020, and 2027
TABLE 169: The Middle East Proteomics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 170: Proteomics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 171: The Middle East Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
IRAN
TABLE 172: Iranian Market for Proteomics: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2020-2027
TABLE 173: Proteomics Market in Iran: Historic Sales Analysis in US$ Million by Component for the Period 2012-2019
TABLE 174: Iranian Proteomics Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 175: Iranian Demand Estimates and Forecasts for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 176: Iranian Proteomics Market in US$ Million by Application: 2012-2019
TABLE 177: Proteomics Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
ISRAEL
TABLE 178: Israeli Proteomics Market Estimates and Forecasts in US$ Million by Component: 2020-2027
TABLE 179: Proteomics Market in Israel in US$ Million by Component: A Historic Review for the Period 2012-2019
TABLE 180: Israeli Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 181: Israeli Proteomics Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 182: Proteomics Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 183: Israeli Proteomics Market Share Analysis by Application: 2012 VS 2020 VS 2027
SAUDI ARABIA
TABLE 184: Saudi Arabian Proteomics Market Growth Prospects in US$ Million by Component for the Period 2020-2027
TABLE 185: Proteomics Historic Market Analysis in Saudi Arabia in US$ Million by Component: 2012-2019
TABLE 186: Saudi Arabian Proteomics Market by Component: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 187: Saudi Arabian Demand for Proteomics in US$ Million by Application: 2020 to 2027
TABLE 188: Proteomics Market Review in Saudi Arabia in US$ Million by Application: 2012-2019
TABLE 189: Saudi Arabian Proteomics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
TABLE 190: Proteomics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 191: United Arab Emirates Proteomics Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 192: Proteomics Market Share Distribution in United Arab Emirates by Component: 2012 VS 2020 VS 2027
TABLE 193: Proteomics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
TABLE 194: United Arab Emirates Proteomics Historic Market Analysis in US$ Million by Application: 2012-2019
TABLE 195: Proteomics Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
TABLE 196: Proteomics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 197: Rest of Middle East Proteomics Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 198: Rest of Middle East Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 199: Proteomics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
TABLE 200: Rest of Middle East Proteomics Market in Retrospect in US$ Million by Application: 2012-2019
TABLE 201: Proteomics Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
AFRICA
TABLE 202: African Proteomics Market Estimates and Projections in US$ Million by Component: 2020 to 2027
TABLE 203: Proteomics Market in Africa by Component: A Historic Review in US$ Million for 2012-2019
TABLE 204: African Proteomics Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 205: African Proteomics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
TABLE 206: Proteomics Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019
TABLE 207: Proteomics Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 75
